Personalis (PSNL.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Nov25

Lake Street Maintains Buy Rating for Personalis with a Target Price of $11.00

13:58

Personalis Inc's CMS revises next individual test reimbursement rate to $4,266

11:55

Nov11

Lake Street Maintains Buy Rating on Personalis

14:27

Nov10

Personalis's NeXT Personal® Breast Cancer Recurrence Monitoring Test Receives Medicare Coverage

14:42

Nov5

Brennan Analyzes and Recommends Healthcare Sector Stocks

11:41

Personalis released FY2025 9 Months earnings on November 4 After-Market (EST), actual revenue USD 52.3 M, actual EPS USD -0.6507

00:00

Schedules & Filings

Schedules

Filings

Nov4

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 14.5 M, Net Income -21.65 M, EPS -0.2441

Aug5

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 17.2 M, Net Income -20.06 M, EPS -0.2265

May6

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 20.61 M, Net Income -15.75 M, EPS -0.18

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change